• Todd Chappell

      M.B.A., Chief Executive Officer

      Todd Chappell is the Chief Executive Officer of Perceptive Navigation, LLC. Mr. Chappell has fifteen years of experience with early-stage, venture-backed biotechnology companies. Most recently, he managed a portfolio of start-up pharmaceutical and medical device companies as an Entrepreneur-in-Residence (EIR) at BioHealth Innovation, Inc.In that role, he also served as the first EIR at the National Institutes of Health (NIH), where he worked with scientists to identify, develop and license commercially relevant technologies.

      From 2009 to 2012, Todd ran Shape Pharmaceuticals, Inc., a portfolio company of HealthCare Ventures, LLC, where he oversaw all day-to-day operations involved in the development of a novel HDAC inhibitor for Cutaneous-T-Cell-Lymphoma through to a human proof-of-concept study. Shape was sold to TetraLogic Pharmaceuticals in 2014 and a Phase 2 clinical study has initiated. Prior to Shape, Mr. Chappell was at CombinatoRx Inc. for eight years and served as Director of New Products. In that role, he oversaw early-stage product development and product strategy across a range of therapeutic areas including inflammation, infectious disease, dermatology, oncology, and ophthalmology.

      Mr. Chappell directly led the advancement of three programs from assay stage into human clinical studies. Mr. Chappell is a co-inventor on over 10 product patents. He holds a B.S. from University of California at Los Angeles and a M.B.A. from Boston University.

      Mike Zipparo

      Ph.D., Ultrasound Engineer

      Dr. Zipparo has over 30 years of experience in ultrasound array and imaging technology. He previously worked for TETRAD, at one time the world’s largest OEM array manufacturer. He then directed R&D at W.L. Gore, another ultrasound technology company. He has particular expertise in catheter based ultrasound and will be invaluable in getting Vu-Path to market. His responsibilities include iterative design of the transducer including in-vitro and in-silico testing, help with decisions on final clinical design and oversee manufacturing design and third-party OEM supplier evaluation.

      Chris Dykes

      B.S., Design Engineer

      Mr. Dykes is an engineer with over 20 years of expertise and experience with medical device design and fabrication. He has previously worked in product development and design with several large publicly traded biomedical companies. His expertise is in catheter design, plastics, ergonomics and mechanical testing. Most recently, Mr. Dykes held a position at GE Medical as a Marketing Product Manager for Infant Care microprocessor controlled thermoregulation microenvironments.

      Pei Zhang

      Ph.D., Research Engineer

      Dr. Zhang has over 20 years experience with biomedical engineering with a significant amount of expertise related to evaluation of various ultrasound technologies. Dr. Zhang has independently performed large animal studies using various imaging modalities and assisted in clinical studies of novel medical devices. She has extensive experience with design, development and testing of novel devices in the pre-clinical and clinical settings. Dr. Zhang’s responsibilities includeperformingin-house testing and coordinating ultrasound machine programming, transducer development, pre-clinical testing and clinical trials.